Ozempic

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012.Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.

Read more in the app

NASA’s Perseverance Rover Ascends, Ozempic Is Linked to Depression, and Mpox Cases Spread Rapidly

People Are Overdosing on Semaglutide Drugs like Ozempic and Wegovy

Ozempic and Wegovy could help people quit smoking

Combining Ayahuasca Compound with Drugs like Ozempic Could Help Treat Diabetes

What’s the Secret behind Ozempic’s Sweeping Health Benefits?

Tracking Ozempic’s Nausea Side Effect to Specific Neurons May Lead to Better Drugs

Study Shows One Drug Performs Better Than Ozempic For Weight Loss

No More Nausea: New Discovery Could Reduce the Side Effects of Ozempic and Wegovy

Some States Say They Can’t Afford Ozempic and Other Weight Loss Drugs

Some States Say They Can’t Afford Ozempic and Other Weight Loss Drugs

Stop criticising Ozempic - it could be a solution to more than obesity

Ozempic and Wegovy linked to lower risk of alcoholism

Ozempic Cuts Risk of Kidney Disease Death in People with Diabetes

You Quit Ozempic or Wegovy. What Happens Next?

Obesity Is Complex: How Drugs Like Ozempic Can Reinforce Fat Stigma

Are Weight-Loss Drugs Like Ozempic For You? Consider These Risks (And Benefits).

Ozempic and Wegovy linked to a lower risk of cannabis use disorder

Experimental Weight-Loss Pill Twice as Effective as Ozempic, Trial Shows

Experimental weight loss pill seems to be more potent than Ozempic

Keto diet helps people maintain weight loss after stopping Ozempic

Quantum Worlds »